搜索筛选:
搜索耗时0.0905秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
发布年度:
Feng Xiaocai.Zhengshang Zhongguo: Yu Qiaqing yu ta de shidai (Political Merchants in China: Yu Qiaqi
[期刊论文] 作者:Kwan Man Bun,
来源:中国历史学前沿 年份:2015
...
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic st
[会议论文] 作者:Xiang Zhang,Jiayun Shen,Kwan Man,Eagle S.H.Chu,Tung On Yau,Joanne C.Y.Sung,Minnie Y.Y.Go,Jun Deng,Liwei,
来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
...
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic st
[会议论文] 作者:Xiang Zhang,Jiayun Shen,Kwan Man,Eagle S.H.Chu,Tung On Yau,Joanne C.Y.Sung,Minnie Y.Y.Go,Jun Deng,Liwei,
来源:中国免疫学会第九届全国免疫学学术大会 年份:2014
Perpetuate liver inflammation is crucial in the pathogenesis of non-alcoholic steatohepatitis (NASH).Expression of CXCL10, a pro-inflammatory cytokine that can recruit inflammatory cells to site of ti...
[会议论文] 作者:Jin Hou,Joyce M.F.Lee,Chung-Mau Lo,Kwan Man,Yuan Yang,Yun Yang,Yin-Yun Yang,Qian Zhang,Xu-Hui Zhu,Nan,
来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and is among the leading causes of cancer-related deaths, especially in China.Systemic and targeted therapies, suc...
[会议论文] 作者:Jin Hou,Joyce M.F.Lee,Chung-Mau Lo,Kwan Man,Yuan Yang,Yun Yang,Yingyun Yang,Qian Zhang,Xuhui Zhu,Nan,
来源:第十三届全国肿瘤生物治疗学术会议 年份:2013
Background and Purposes: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and is among the leading causes of cancerrelated death, especially in China.Systemic and targeted th...
[会议论文] 作者:钦伦秀,李楠,孙惠川,杨云,罗宗茂,于益芝,Joyce M.F.Lee,丁国善,Kwan Man,曹雪涛,杨莹韵,周烨,侯晋,樊嘉,周伟平,吕爱莲,
来源:第十四届全国肿瘤生物治疗大会 年份:2015
干扰素(IFN)目前被广泛应用于恶性肿瘤的临床治疗,但其在治疗恶性肿瘤尤其是肝细胞肝癌时在患者中存有较大的疗效差异.探求IFN-α疗效预判分子靶标并进行相应干预是IFN应...
[会议论文] 作者:杨云,王正昕,谢裕安,梁庭波,杨远,李楠,罗小玲,夏强,杨莹韵,丁国善,梁安民,于益芝,张迁,庄诗美,王铸钢,曹雪涛,Kwan Man,朱旭辉,郑利民,张明,侯晋,周烨,郑媛媛,樊嘉,周伟平,吕爱莲,孙惠川,
来源:第十四届全国肿瘤生物治疗大会 年份:2015
肝细胞肝癌尤其是乙肝相关肝癌是我国目前的重大疾病,干扰素治疗是临床治疗肝癌的重要手段,但部分患者对于干扰素治疗敏感性较差,目前尚缺乏肝癌干扰素治疗疗效预判行之有效......
[会议论文] 作者:侯晋,周烨,郑媛媛,樊嘉,周伟平,吕爱莲,孙惠川,钦伦秀,邱双建,Joyce M.F.Lee,罗宗茂,Kwan Man,杨远,杨云,杨莹韵,张迁,朱旭辉,李楠,王正昕,丁国善,庄诗美,郑利民,罗小玲,谢裕安,
来源:第十四届全国肿瘤生物治疗大会 年份:2015
肝细胞肝癌尤其是乙肝相关肝癌是我国目前的重大疾病,干扰素治疗是临床治疗肝癌的重要手段,但部分患者对于干扰素治疗敏感性较差,目前尚缺乏肝癌干扰素治疗疗效预判行之有效的分子标志物,使得肝癌干扰素治疗的临床应用面临重大瓶颈。......
相关搜索: